Evidence map›Paper›PMID 39901738›Full record

ArticleJournal of Crohn's & colitis2025

Nonconventional dysplasia in patients with inflammatory bowel disease and colorectal adenocarcinoma: a case-cohort study.

Siri A Urquhart, Namratha Pallipamu, Hima Varsha Voruganti, Bhavana Baraskar, Pratyusha Muddaloor, Arshia K Sethi, Renisha Redij, Keirthana Aedma, Keerthy Gopalakrishnan, Shivaram Poigai Arunachalam and 6 more

Abstract read
In one paragraph

Article in Journal of Crohn's & colitis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Siri A UrquhartDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States.ORCID 0000-0002-2337-0480
Namratha PallipamuDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States.
Hima Varsha VorugantiDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States.
Bhavana BaraskarDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States.
Pratyusha MuddaloorDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States.
Arshia K SethiDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States.
Renisha RedijDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States.
Keirthana AedmaDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States.
Keerthy GopalakrishnanDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States.
Shivaram Poigai ArunachalamDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States.
Kelli N BurgerDepartment of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, United States.
Douglas W MahoneyDepartment of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, United States.
Blake A KassmeyerDepartment of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, United States.
Ryan J LennonDepartment of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, United States.
John B KisielDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States.
Nayantara Coelho-PrabhuDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States.

Funding

Multi-site Gastrointestinal Cancer Detection by Stool DNA MethylationR37CA214679 · NCI · MAYO CLINIC ROCHESTER · PI KISIEL, JOHN · 2018 to 2024
$2.8M
Multi-cancer Early DetectionR01CA214679 · NCI · MAYO CLINIC ROCHESTER · PI John Kisiel, Niloy Jewel Samadder · 2025 to 2026
$891k
J.B.K CA214679NCI NIH HHS R01 CA214679NCI NIH HHS R37 CA214679
6 · The paper itself

Abstract

BACKGROUND AND

aimsPatients with inflammatory bowel disease (IBD) face increased risk of colorectal cancer (CRC). While the natural history of conventional dysplastic precursor lesions has been well-studied, the neoplastic potential of recently described nonconventional (NC) IBD-associated colonic mucosal lesions is unclear. We aimed to assess the incidence of antecedent NC lesions in patients with IBD who developed CRC.

methodsA case-cohort study was performed to include patients with a diagnosis of IBD with or without CRC who underwent at least 2 surveillance endoscopic procedures at our institution between 1/1/2007 and 5/31/2023. NC lesions included serrated change and indefinite for dysplasia. Detection rates pre- and post-introduction of high-definition (HD) surveillance colonoscopy were compared.

resultsIn total, 87 patients with IBD and CRC and 200 patients with IBD without CRC were identified. Of the cases, a majority had ulcerative colitis (n = 52, 60%), most commonly with extensive involvement (n = 46, 89%). Conventional (hazard ratio [HR] 2.18, 95% confidence interval [CI] 1.34-3.52) and NC (HR 2.28, 95% CI 1.59-3.26) lesions were associated with increased risk of CRC. Conventional lesions in the post-HD era appeared to have a stronger association with CRC (HR 2.79, 95% CI 1.62-4.77) than NC lesions (HR 1.62, 95% CI 0.86-3.06).

conclusionsBoth conventional and NC lesions seem to be associated with increased risk of CRC. Conventional lesions are more strongly associated with CRC than NC lesions in the post-HD era, but misclassifications in the pre-HD era may have resulted in a biased increased risk estimate for NC lesions.

Indexed as

AdenocarcinomaColitis, UlcerativeColorectal NeoplasmsInflammatory Bowel DiseasesPrecancerous ConditionsAdultAgedCase-Control StudiesColonoscopyFemaleHumansIncidenceIntestinal MucosaMaleMiddle Agedcolorectal neoplasmsinflammatory bowel disease

Identifiers

PMID39901738
PMCPMC13032021

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.